Kacper A Walentynowicz, PhD
@kacperwphd.bsky.social
Research Associate at Memorial Sloan Kettering Cancer Center
ex-MSCA PhD Fellow
mix of science and other bits!
views my own not of my employer, he/him
https://walentk.github.io
🇪🇺🏳️🌈
ex-MSCA PhD Fellow
mix of science and other bits!
views my own not of my employer, he/him
https://walentk.github.io
🇪🇺🏳️🌈
Reposted by Kacper A Walentynowicz, PhD
📢 Today we celebrate International Day of LGBTQIA+ People In STEM!
📷 A drop of rainbow” (Lara Barrio): 🔴🟢🔵 With just three fluorescent markers it's possible to generate 7 colour combinations that allow researchers to track multiple cell populations in #Drosophila.
#LGBTQSTEMDay #PrideInSTEM
🧪
📷 A drop of rainbow” (Lara Barrio): 🔴🟢🔵 With just three fluorescent markers it's possible to generate 7 colour combinations that allow researchers to track multiple cell populations in #Drosophila.
#LGBTQSTEMDay #PrideInSTEM
🧪
November 18, 2025 at 10:30 AM
📢 Today we celebrate International Day of LGBTQIA+ People In STEM!
📷 A drop of rainbow” (Lara Barrio): 🔴🟢🔵 With just three fluorescent markers it's possible to generate 7 colour combinations that allow researchers to track multiple cell populations in #Drosophila.
#LGBTQSTEMDay #PrideInSTEM
🧪
📷 A drop of rainbow” (Lara Barrio): 🔴🟢🔵 With just three fluorescent markers it's possible to generate 7 colour combinations that allow researchers to track multiple cell populations in #Drosophila.
#LGBTQSTEMDay #PrideInSTEM
🧪
Thank you for the recognition! ☺️ @mskcancercenter.bsky.social @mskeducation.bsky.social
Meet #MSKPostdoc Kacper Walentynowicz (@kacperwphd.bsky.social) in the Parada Lab! He studies how brain tumors interact with the immune system, using cutting-edge tech to harness immune cells like macrophages for innovative cancer therapies 🧠🧬💥
#NPAW2025🇵🇱
#NPAW2025🇵🇱
September 26, 2025 at 6:41 PM
Thank you for the recognition! ☺️ @mskcancercenter.bsky.social @mskeducation.bsky.social
Reposted by Kacper A Walentynowicz, PhD
We're back with another exciting session — this time, spotlight on microglial cells!
And wait until you see our star-studded lineup of speakers!
Don't miss it — join us and stay at the forefront of the latest research!
@soyonhonglab.bsky.social
#WGC #GLIA
And wait until you see our star-studded lineup of speakers!
Don't miss it — join us and stay at the forefront of the latest research!
@soyonhonglab.bsky.social
#WGC #GLIA
July 21, 2025 at 2:44 PM
We're back with another exciting session — this time, spotlight on microglial cells!
And wait until you see our star-studded lineup of speakers!
Don't miss it — join us and stay at the forefront of the latest research!
@soyonhonglab.bsky.social
#WGC #GLIA
And wait until you see our star-studded lineup of speakers!
Don't miss it — join us and stay at the forefront of the latest research!
@soyonhonglab.bsky.social
#WGC #GLIA
I'm excited to share that I've been selected to join the Life Sciences Technology Innovation Fellows Program at Cornell SC Johnson College of Business. The future is bright! @scjohnsoncollege.bsky.social #entrepreneurship #science
Life Sciences Technology Innovation Fellows Program - Entrepreneurship at Cornell
Read more about BioEntrepreneurship
eship.cornell.edu
May 5, 2025 at 1:49 PM
I'm excited to share that I've been selected to join the Life Sciences Technology Innovation Fellows Program at Cornell SC Johnson College of Business. The future is bright! @scjohnsoncollege.bsky.social #entrepreneurship #science
Reposted by Kacper A Walentynowicz, PhD
Single-cell RNA sequencing of immune cells for over 1,000 people age 18-97 years. A clock of our immune system aging. Tells us about an individual's response to infection, vaccination, Long Covid. Towards an immunome.
www.nature.com/articles/s43...
www.nature.com/articles/s43...
March 5, 2025 at 2:53 PM
Single-cell RNA sequencing of immune cells for over 1,000 people age 18-97 years. A clock of our immune system aging. Tells us about an individual's response to infection, vaccination, Long Covid. Towards an immunome.
www.nature.com/articles/s43...
www.nature.com/articles/s43...
Reposted by Kacper A Walentynowicz, PhD
Going to the 2025 #MIT #European #Career #Fair this weekend, & wondering how to #fund your future #research?
Visit the 🇪🇺 European Union's stand to find out all about European Research Council's #grants!
Info 👉 europa.eu/!M4MWm8
#EURAXESS #Europe #Science #Grant #Funding @mitofficial.bsky.social
Visit the 🇪🇺 European Union's stand to find out all about European Research Council's #grants!
Info 👉 europa.eu/!M4MWm8
#EURAXESS #Europe #Science #Grant #Funding @mitofficial.bsky.social
February 26, 2025 at 3:00 PM
Functional differences between rodent and human PD-1 linked to evolutionary divergence | Science Immunology www.science.org/doi/10.1126/...
Functional differences between rodent and human PD-1 linked to evolutionary divergence
A highly conserved motif in human PD-1 but absent in rodent PD-1 is linked to differential inhibitory activity.
www.science.org
February 25, 2025 at 8:55 PM
Functional differences between rodent and human PD-1 linked to evolutionary divergence | Science Immunology www.science.org/doi/10.1126/...
Reposted by Kacper A Walentynowicz, PhD
Carisma Therapeutics reports Phase 1 results of CT-0508, an anti-HER2 CAR #macrophage that has already been deprioritized, in advanced/metastatic #HER2 overexpressing solid tumors (14 pts). CAR-M therapy is feasible and well-tolerated.
@natmedicine.bsky.social
www.nature.com/articles/s41...
@natmedicine.bsky.social
www.nature.com/articles/s41...
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial - Nature Medicine
In a first-in-human phase 1 trial, HER2-specific CAR macrophages were feasible to manufacture and well tolerated, with no dose-limiting toxicities in patients with HER2-overexpressing solid tumors.
www.nature.com
February 11, 2025 at 10:19 AM
Carisma Therapeutics reports Phase 1 results of CT-0508, an anti-HER2 CAR #macrophage that has already been deprioritized, in advanced/metastatic #HER2 overexpressing solid tumors (14 pts). CAR-M therapy is feasible and well-tolerated.
@natmedicine.bsky.social
www.nature.com/articles/s41...
@natmedicine.bsky.social
www.nature.com/articles/s41...
Happy to announce my collaboration with Miltenyi Biotec, using their spatial platform to study cellular crosstalk and vulnerabilities for CAR-macrophage treatment in GBM!
Miltenyi Biotec on LinkedIn: The application period for the 2024 MACS® Imaging Grant program has…
The application period for the 2024 MACS® Imaging Grant program has concluded. We are honored that so many researchers shared their brilliant ideas with us on…
www.linkedin.com
January 8, 2025 at 9:31 PM
Happy to announce my collaboration with Miltenyi Biotec, using their spatial platform to study cellular crosstalk and vulnerabilities for CAR-macrophage treatment in GBM!